When Rabelais Meets Balard

The Biology-Health (BS) and Chemistry Research Clusters at the University of Montpellier are organizing a Chemistry/BS networking event on July 9, which will focus on the topic of cancer.

This event, organized in collaboration with the Cancéropôle Grand Sud-Ouest, aims to highlight existing collaborative projects between these two cancer research centers within the Montpellier community. 

We are delighted to welcome Patrick Mehlen from the CRCL and Frédéric Thomas from Mivegec for two plenary lectures. The day’s program will include presentations by two PTLs—CARLA from the Chemistry Cluster and COSMIC from the Biology and Health Cluster —as well as two success stories at the end of the day.

Program

9:00 a.m. – 9:30 a.m.: OPENING REMARKS by Philippe Augé, President of the University of Montpellier
, and Pascal Dumy, Director of ENSCM
Introduction by the directors of the Chemistry and Biology-Health Divisions
Joulia Larionova, Chemistry Division
Pierre-Emmanuel Milhiet, Biology-Health Division

9:30 a.m. – 10:15 a.m.: PLENARY LECTURE
: Targeting netrin-1 in cancer: From cell biology concepts to clinical data
Patrick Mehlen, Lyon Cancer Research Center ( Research ) (CRCL) and Léon Bérard Center

10:15 a.m. – 10:45 a.m.: Unlocking the Power of RNA Chemistry in Personalized Medicine
, Alexandre David, IRCM

10:45 a.m. – 11:05 a.m.: Break and poster session

11:05 a.m. – 11:35 a.m.: Targeted nanovectors for photodynamic therapy of cancers
, Magali Gary-Bobo, IBMM

11:35 a.m. – 12:05 p.m.: Encapsulation of MDM2 degraders in polydepsipeptide microparticles for the treatment of liposarcoma
, Emmanuel Belamie, ICGM, and Laetitia Linares, IRCM

12:05 p.m. – 1:30 p.m.: Lunch break and poster session

1:30 p.m. – 2:15 p.m.: PLENARY SESSION | Evolution and Cancer
, Frédéric Thomas, Mivegec

2:15 p.m. – 2:35 p.m.: Presentation of the GSO Cancer Center
, Karine Marendziak, and Karine Saget, GSO Cancer Center

2:35 p.m. – 3:05 p.m.: Impact of DNA methylation on platinum adduct formation: Development of bifunctional derivatives combining cisplatin and inhibitors of DNA methyltransferases
, Marie Lopez, IBMM, and Philippe Pourquier, IRCM

3:05 p.m. – 3:35 p.m.: Turning Ligands into Liabilities: PROTAC-mediated PXR degradation to delay colon cancer relapse
, Anthony Martin, IBMM

3:35 p.m. – 4:05 p.m.: Fluorescent Biosensor Technologies for Diagnostics and Drug Discovery
. May Morris, IBMM

4:05 p.m. – 4:20 p.m.: Break and poster session

4:20 p.m. – 4:35 p.m.: CARLA Long-Term Thematic Project (PTL), Sustainable Chemistry for Health
; Camille Oger, IBMM; and Sébastien Blanquer, ICGM

4:35 p.m. – 4:50 p.m.: COSMIC Long-Term Thematic Project (PTL), Complex Organoid Systems with Multifaceted Interactions
, Matteo Bonazzi, IRIM

4:50 p.m. – 5:10 p.m.: Glycomimetics and Cancer: Design, Formulation, and Clinical Trials
; David Virieux, ICGM; and Philippe Legrand, ICGM

5:10–5:25 p.m.: Presentation by ChemBioFrance-Chimiothèque Nationale / CNRS
, Mikaël Le Clech, ChemBioFrance

5:30 p.m.: End of the day